Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

FREJA

Financiado

Foldable, REconfigurable & Jagged devices for enhanced drug Absorption/seeding

Oral delivery of protein/peptide drugs is extremely challenging and the majority of research in the field is based on exploring new formulations, for instance using permeation enhancers. In recent years, some research has been don... ver más

30/09/2027

TECHNICAL UNIVERSI...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-08-10

ERC-2021-ADG: ERC ADVANCED GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

TECHNICAL UNIVERSITY OF DENM...

2.56M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2021-128417OB-I00 NANOBOTS BIOCOMPATIBLES COMO NANOVEHICULOS EFICIENTES PARA A... 284K€ Cerrado

PID2021-126244NA-I00 MATERIALES BLANDOS QUIMICAMENTE ALIMENTADOS CON FUNCIONES SI... Cerrado

PID2020-119914RB-I00 NANOMEDICINAS DE PRECISION QUE PENETRAN EL CEREBRO 254K€ Cerrado

PRE2019-088033 Targeted therapeutics and nanodevices 98K€ Cerrado

PDC2021-121409-I00 PLATAFORMA DE MICROFLUIDICA PARA LIBERACION DE FARMACOS CONT... 150K€ Cerrado

BES-2010-030593 MODIFICACION DE CAPSIDAS VIRICAS POR INGENIERIA DE PROTEINAS... 43K€ Cerrado

Duración del proyecto: 61 meses Fecha Inicio: 2022-08-10
Fecha Fin: 2027-09-30

Líder del proyecto

DANMARKS TEKNISKE UNIVERSITET No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 3M€

Descripción del proyecto Oral delivery of protein/peptide drugs is extremely challenging and the majority of research in the field is based on exploring new formulations, for instance using permeation enhancers. In recent years, some research has been done on ingestible devices for internal injections. Here I propose an entirely new approach based on what we have named ‘Self-configurable, Proximity Enabling Devices’ (SPEDs). The idea is that these devices (the simplest ones will be rolled-up foils) will unfold in the gut, embed in the mucus layer and align to the intestinal wall. It is essential that the SPED has close proximity to the intestinal wall and is retained for a while in order to ensure efficient drug delivery. The proximity will additionally allow us to study and explore the influence of nanotextures (embedded in the SPED) on the interaction with the intestinal wall as well as micromotor-based delivery. The SPEDs will be developed and characterized with the following specific objectives: (i) understanding the SPED properties needed to penetrate mucus, (ii) investigating the mechanisms for enhanced retention time, (iii) exploring the SPED as a carrier for self-propelling cargo, (iv) unraveling the overall behaviour of SPED and (v) demonstrating anti-diabetic drug formulation delivery with at least 5 % systemic uptake and show feasibility of a wider range of applications (delivering/seeding e.g. peptide and proteins/vaccines/probiotics). The work will include simulations of soft materials, device design, micro/nano fabrication, development and use of techniques for mechanical characterisation of device/tissue interaction, bio imaging and in vitro and in vivo studies. The major novelty lies in the SPED concept, providing tissue alignment/contact and unidirectional drug release. Further, the SPEDs provide a unique platform for studies on micromotors as well as nanotextures interaction with the epithelium.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores